A study supported by the National Institutes of Health (NIH) finds that individuals who received medication for opioid use disorder (MOUD) while incarcerated were significantly more likely to continue ...
A study published in The New England Journal of Medicine finds that individuals who received medication for opioid use disorder (MOUD) while incarcerated were significantly more likely to continue ...
Please provide your email address to receive an email when new articles are posted on . PF614-MAR helps prevent overdoses by “shutting down” active drug release if too much has been consumed, the ...
Extended-release buprenorphine is approved as a once-monthly subcutaneous injection for the treatment of moderate-to-severe ...